XML 15 R5.htm IDEA: XBRL DOCUMENT v3.3.1.900
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Cash flows from operating activities    
Net loss $ (27,233) $ (3,290)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 1,632 1,364
Amortization of debt issuance costs 75 75
Impairment of property and equipment and intangible assets 2,515 276
Provision for bad debt expense and note receivable 579 0
Interest costs added to principal balance of notes payable 946 1,132
Share-based compensation expense 6,096 3,731
Earnings from equity method investments (5,133) (22,019)
Other non-cash items, net 191 53
Changes in operating assets and liabilities, net of effects of acquired businesses:    
Receivables 7,579 (2,712)
Related party receivables (752) (927)
Prepaid expenses and other assets (1,134) (812)
Costs incurred on uncompleted contracts 4,719 (44,475)
Restricted cash 0 0
Restricted cash, long-term 1,690 (1,212)
Other long-term assets 144 (81)
Accounts payable 1,414 3,002
Accrued payroll and related liabilities 1,161 166
Other current liabilities 1,624 (929)
Billings on uncompleted contracts (7,256) 39,736
Advance deposit, related party (2,586) (1,417)
Other long-term liabilities 98 163
Settlement and royalty indemnification obligation (2,528) (3,914)
Distributions from equity method investees, return on investment 2,519 1,259
Net cash used in operating activities (13,640) (30,831)
Cash flows from investing activities    
Purchase of investment securities, restricted 0 105
Maturity of investment securities, restricted 0 404
Increase in restricted cash (2,100) (1,243)
Acquisition of property and equipment (437) (1,218)
Advance on note receivable (500) 0
Acquisition of business (2,124) 0
Purchase of and contributions to equity method investees (1,083) (5,132)
Distributions from equity method investees in excess of cumulative earnings 4,730 22,547
Net cash provided by (used in) investing activities (1,514) 15,463
Cash flows from financing activities    
Repayments on notes payable (1,166) 0
Proceeds received upon exercise of stock options 0 243
Repurchase of shares to satisfy minimum tax withholdings (276) (1,298)
Net cash used in financing activities (1,442) (1,055)
Increase (Decrease) in Cash and Cash Equivalents (16,596) (16,423)
Cash and Cash Equivalents, beginning of period 25,181 37,890
Cash and Cash Equivalents, end of period 8,585 21,467
Supplemental disclosures of cash information:    
Cash paid for interest 5,335 1,917
Cash paid for income taxes 186 106
Restricted stock award reclassification (equity to liability) 0 501
Issuance of common stock to settle liabilities 0 127
Acquisition of equity method investment through note payable $ 0 $ 13,301